Yorkville Advisors — Full Portfolio

HealthtechSalt Lake City, US

Timothy Pickett(Executive Officer, Director)Jared Barrera(Executive Officer)Adam Cox(Executive Officer, Director)

BoardGary Seelhorst(Director)Amy Powell(Director)Christian Robinson(Director)

Co-investorsACTAI VenturesArrington CapitalOff the Chain Capital

Northwest Biotherapeutics is a clinical-stage biotechnology company developing personalized cancer vaccines, marketed under the DCVax platform, that use activated dendritic cells to treat a range of solid tumor cancers.

BiotechHealthtechBethesda, US

Alton Boynton(Executive Officer, Director)Linda F Powers(Executive Officer, Director)Marnix Bosch(Executive Officer)Leslie Goldman(Executive Officer)

BoardNavid Malik(Director)Jerry Jasinowski(Director)

Co-investorsVedanta Capital

Eden Prairie, US

Jeffrey Yu(Executive Officer, Director)Lisa Embree(Executive Officer)Aaron Green(Executive Officer, Director)THOMAS HIATT(Director)JERRY HIATT(Executive Officer, Director)CHRISTOPHER HANNA(Executive Officer, Director)

NASDAQ-listed company harnessing immunology for therapeutic development

BiotechNorth Brunswick, US

Frank K. Bedu-Addo(Executive Officer)

Co-investorsEMV Capital

Predictive Oncology combines machine learning with data from a large privately held biobank of over 150,000 tumor samples and 3D in vitro tumor models to predict drug response for pre-clinical drug discovery.

Advanced ManufacturingAI & Machine LearningBiotechHealthtechPittsburgh, US

Josh Blacher(Executive Officer)inRaymond Vennare(Executive Officer, Director)inCarl I Schwartz(Executive Officer, Director, Promoter)Bob Myers(Executive Officer)inJoshua Kornberg(Executive Officer, Director)Ricardo Koenigsberger(Director)